Seeking Alpha
View as an RSS Feed

Brendan O'Boyle  

View Brendan O'Boyle's Comments BY TICKER:
Latest  |  Highest rated
  • Reports: Qualcomm planning layoffs, could cut over 10% of workers [View news story]
    I feel like announcing layoffs right before a quarterly report bodes poorly for the quarterly report...

    I guess we'll see tomorrow.
    Jul 20, 2015. 04:59 PM | 6 Likes Like |Link to Comment
  • Weighing The Week Ahead: Will Falling Earnings Sink The Stock Market? [View article]
    Saying bonds are going down and investors should move from funds to individual bonds is like saying a bear market is on the horizon and you should sell your mutual funds and buy individual stocks.

    There is a chance you will do better if you pick bonds (stocks) well, but I wouldn't count on it.

    Think about it, if individual bonds could be chosen that automatically outperformed funds it would be the arbitrage opportunity of the century.
    Jul 12, 2015. 02:18 PM | Likes Like |Link to Comment
  • Will Greece be in or out? [View news story]
    If Europe stops funding the Greek banks Greece will be forced to issue its own currency. No bailout means Greece will be forced to abandon the Euro. So I would say your statement is incorrect.
    Jul 8, 2015. 06:50 AM | 1 Like Like |Link to Comment
  • The REIT Bloodbath: Game Plan For 2nd Half [View article]
    At that time the phrase 'bloodbath' might become appropriate.

    But that is what might happen, not what has happened.
    Jul 7, 2015. 10:49 AM | Likes Like |Link to Comment
  • The REIT Bloodbath: Game Plan For 2nd Half [View article]
    It depends on the REIT. Down 25% is pretty bad, but the overall index isn't a bloodbath IMHO.

    10% is a correction, not a bloodbath.
    Jul 6, 2015. 04:38 PM | 4 Likes Like |Link to Comment
  • One Photo That Will Convince You To Sell China [View article]
    Long BABA and BABA?

    Maybe it's a typo and he's long ABBA? Mamma Mia here we go again...
    Jul 6, 2015. 03:59 PM | 55 Likes Like |Link to Comment
  • The REIT Bloodbath: Game Plan For 2nd Half [View article]
    A couple points:

    First, I think using 'bloodbath' or 'carnage' to describe a 5.7% YTD decline is a bit much.

    Second, you should use total return not price return for your REIT vs. SPY chart. On a total return basis REITs were neck and neck with the S&P 500 before this pullback and are now slightly behind. You can't expect REITs to payout 4% a year and keep pace with the S&P 500 in price.
    Jul 6, 2015. 03:37 PM | 11 Likes Like |Link to Comment
  • It Is Not Priced-In, Stupid! [View article]
    How do you price in something that hasn't happened yet?
    Jul 6, 2015. 03:21 PM | 1 Like Like |Link to Comment
  • Why Beating The S&P 500 Is So Hard, And Why Even Protecting Against A 10-15% Correction Matters [View article]
    I just wonder how much of RSP's outperformance relative to SPY is simply due to the fact that it is more concentrated in mid-cap stocks. These have overall outperformed large-caps.

    RSP has a weighted average market cap of $40B vs. $137B for SPY.

    You might get the same result mixing in VO (Vanguard's mid-cap ETF) with SPY.
    Jul 5, 2015. 01:14 PM | 5 Likes Like |Link to Comment
  • Is Realty Income Cheap Enough Yet? [View article]
    8-10% is total return, about half and half from the dividend and probable price appreciation.

    I wrote an article a while back to this effect. I'm probably lowballing a bit at 8-10%. The numbers say 11% over 5 Yrs at $45/share.

    http://bit.ly/1HzKlQD
    Jul 2, 2015. 12:37 PM | Likes Like |Link to Comment
  • Is Realty Income Cheap Enough Yet? [View article]
    Both short and long-term rates generally move in the same direction.

    Another misconception that investors have is expecting historically normal Treasury rates any time in the near future. It's going to be a long time before the ten year yields 4-5%.

    Furthermore, since 1995 the average yield of O has been 5.6%, while the average yield of a 10-Year has been 4.3%. The spread is so much wider than the historical average it would lead one to believe that O is massively underpriced.

    Being bearish on O because of rates simply makes no sense.
    Jul 2, 2015. 11:57 AM | 3 Likes Like |Link to Comment
  • Is Realty Income Cheap Enough Yet? [View article]
    The idea that REITs go down as short-term rates go up is a misnomer that has been repeated so many times that everyone is convinced that its true.

    The WSJ did an article on exactly this and found that REITs perform better during periods of rising rates than falling rates.

    Add to that we will never see short-term rates that are competitive with O's present yield (and that neglects growth anyway). The whole game surrounding a rate hike never ceases to amaze, REITs have been preposterously volatile for the last 2 years. It makes very little sense as the Fed has stayed consistent in its timeline, yet investors feel the need to bid O up to 55 and back to 40 again and again.

    $44-45 is fairly valued and a 5 Yr investment will probably garner an 8-10% CAGR.
    Jul 2, 2015. 09:50 AM | 7 Likes Like |Link to Comment
  • Biogen Sells Off On Short-Term Worries, But It's The Pipeline That Will Reward Long-Term Investors [View article]
    A Scifinder search of "Beta Amyloid Hypothesis" generates about 1350 references.

    The company has multiple drugs in development because they know the odds of any one being successful are low. However, Biogen is not putting a drug into phase 3 if they don't think it is a good bet.

    So yes aducanumab may prove to be unsuccessful only time will tell. But the reason that it will be a $10B drug if successful is because having a successful Alzheimer's drug is very difficult.
    May 7, 2015. 04:57 PM | Likes Like |Link to Comment
  • Biogen Sells Off On Short-Term Worries, But It's The Pipeline That Will Reward Long-Term Investors [View article]
    I had not realized that. Thanks for bringing it to my attention, I submitted edits to fix the typo.
    May 1, 2015. 12:52 PM | 3 Likes Like |Link to Comment
  • Biogen Sells Off On Short-Term Worries, But It's The Pipeline That Will Reward Long-Term Investors [View article]
    Bear in mind the IBB has fallen 12% from its 52-week high, so BIIB has underperformed its benchmark by about 10%. Most of that has come since the last quarterly report (4/24 when the stock was at $430), so I have to think the market is upset that Biogen didn't surpass growth expectations with its existing product lines.

    I will concede that BIIB couldn't hold onto gains following its phase 1B aducanumab study, and that is probably due to the concerns that you mentioned. Given the terrible effects of Alzheimer's and reading the results from the phase 1B study, it seems to me that aducanumab is an amazing drug candidate. It is the only drug candidate for Alzheimer's ever profiled that has been shown to reduce the size of amyloid plaques, IMO the market should have bid BIIB higher.
    Apr 30, 2015. 08:27 PM | 5 Likes Like |Link to Comment
COMMENTS STATS
1,208 Comments
1,720 Likes